Skip to main content
PMC home page
Elsevier - PMC COVID-19 Collection logoLink to Elsevier - PMC COVID-19 Collection
. 2007 Sep 28;1:375–410. doi: 10.1016/S1874-5326(07)80037-8

13 Ebola virus: where does it come from and where is it going?

Frederick A Murphy 1, CJ Peters 2
PMCID: PMC7172957

Publisher Summary

This chapter discusses the emergence and natural history of Ebola viruses. The fact that the Ebola virus subtypes, which have caused human disease episodes, have been different from one another makes it clear that a common source human-to-human transmission chain extending across sub-Saharan Africa is not the case and rather, virus subtypes lodged at or near each site of the recent human disease episodes have been responsible. Filovirus virions are enveloped and pleomorphic, appearing filamentous or bacilliform, U-shaped, 6-shaped, or circular. Particles have a uniform diameter of 80 nm, but vary greatly in length. The degree of the stability of filovirus sequences overall and the absence of genetic variability among Ebola virus isolates obtained within an outbreak match the character of other member viruses of the order, Mononegavirales. In rhesus monkeys, cynomolgus monkeys, African green monkeys, and baboons inoculated with Marburg virus or the Zaire subtype of Ebola virus, the incubation period is 4–6 days, during which time virus replicates to high titer in the reticuloendothelial system, endothelium, liver, and lungs. It is found that with the onset of clinical disease, there is severe necrosis of these target organs, which is most evident in the liver and there is an interstitial hemorrhage, which is most evident in the gastrointestinal tract.

References

  1. Amblard J., Obiang P., Prehaud C., Prehaud C., Bouloy M., LeGuenno B. Identification of the Ebola virus in Gabon in 1994. Lancet. 1997;349:181–182. doi: 10.1016/S0140-6736(05)60984-1. [DOI] [PubMed] [Google Scholar]
  2. American Committee on Arthropod-Borne Viruses . “International Catalogue of Arboviruses”. American Society of Tropical Medicine and Hygiene; San Antonio, Texas: 1985. [Google Scholar]
  3. Baron R.C., McCormick J.B., Zubeir O.A. Ebola hemorrhagic fever in southern Sudan: hospital dissemination and intrafamilial spread. Bull. WHO. 1983;6:997–1003. [PMC free article] [PubMed] [Google Scholar]
  4. Bazhutin N.B., Belanov E.F., Spiridonov V.A., Voitenko A.V., Krivenchuk N.A., Krotov S.A., Omelchenko N.I., Tereschenko A.Y., Khomichev W. The influence of the methods of experimental infection with Marburg virus on the features of the disease process in green monkeys [in Russian] Vopr. Virusol. 1992;37:153–156. [PubMed] [Google Scholar]
  5. Becker Y. Retrovirus and filovirus immunosuppressive motif and the evolution of virus pathogenicity in HIV-1, HIV-2, and Ebola viruses. Virus Genes. 1995;11(2–3):191–195. doi: 10.1007/BF01728658. [DOI] [PubMed] [Google Scholar]
  6. Belanov Y.F., Muntyanov V.P., Kryuk V.D., Sokolov A.V., Bormotov N.I., P’yankov O.V., Sergeyev A.N. Retention of Marburg virus infecting capability on contaminated surfaces and in aerosol particles [in Russian] Vopr. Virusol. 1996;41(1):32–34. [PubMed] [Google Scholar]
  7. Borisevich I.V., Mikhailov V.V., Krasnianskii V.P., Gradoboev V.N., Lebedinskaia E.V., Potryvaeva N.V., Timan’kova G.D. Development and study of the properties of immunoglobulin against Ebola fever [in Russian] Vopr. Virusol. 1995;40(6):270–273. [PubMed] [Google Scholar]
  8. Bowen E.T.W., Lloyd G., Harris W.J., Platt G.S., Baskerville A., Vella E.E. Viral haemorrhagic fever in southern Sudan and northern Zaire. Lancet. 1977;1:571–573. doi: 10.1016/s0140-6736(77)92001-3. [DOI] [PubMed] [Google Scholar]
  9. Burkreyev A.A., Volchkov V.E., Blinov V.M., Netesov S.V. The G-P protein of Marburg virus contains a region similar to the immunosuppressive domain of oncogenic retro-virus P15E proteins. FEBS Lett. 1993;323:183–187. doi: 10.1016/0014-5793(93)81476-g. [DOI] [PubMed] [Google Scholar]
  10. Calain P. Protective measures and management of Ebola patients; Proceedings of International Colloquium on Ebola Virus Research, Antwerp.; 1996. [Google Scholar]
  11. Casals J. Procedures for identification of arthropod-borne viruses. Bull. WHO. 1961;24:727–734. [PMC free article] [PubMed] [Google Scholar]
  12. Casals J. Immunological techniques for animal viruses. In: Maramorosch K., Koprowski H., editors. Vol. 1. Academic Press; New York: 1967. pp. 113–198. (“Methods in Virology”). [Google Scholar]
  13. Centers for Disease Control and Prevention Update: Filovirus infection among persons with occupational exposure to nonhuman primates. Morbid. Mortal. Weekly Rep. 1990;39:266–273. [PubMed] [Google Scholar]
  14. Centers for Disease Control and Prevention Update: Filovirus infection in animal handlers. Morbid. Mortal. Weekly Rep. 1990;39:221. [PubMed] [Google Scholar]
  15. Centers for Disease Control and Prevention . “Addressing Emerging Infectious Disease Threats, A Prevention Strategy for the United States.”. Centers for Disease Control and Prevention and Prevention; Atlanta, Georgia: 1994. [Google Scholar]
  16. Centers for Disease Control and Prevention Outbreak of Ebola viral hemorrhagic fever—Zaire, 1995. Morbid. Mortal. Weekly Rep. 1995;44(19):381–382. [PubMed] [Google Scholar]
  17. Centers for Disease Control and Prevention Update: Outbreak of Ebola viral hemorrhagic fever—Zaire, 1995. Morbid. Mortal. Weekly Rep. 1995;44(20):399. [PubMed] [Google Scholar]
  18. Centers for Disease Control and Prevention Update: Outbreak of Ebola viral hemorrhagic fever—Zaire, 1995. Morbid. Mortal. Weekly Rep. 1995;44(25):468–475. [PubMed] [Google Scholar]
  19. Centers for Disease Control and Prevention Update: Management of patients with suspected viral hemorrhagic fever—United States. Morbid. Mortal. Weekly Rep. 1995;44(25):475–479. [PubMed] [Google Scholar]
  20. Centers for Disease Control and Prevention Ebola-Reston virus infection among quarantined nonhuman primates—Texas, 1996. Morbid. Mortal. Weekly Rep. 1996;44(15):314–316. [PubMed] [Google Scholar]
  21. Centers for Disease Control and Prevention/National Institutes of Health . “Biosafety in Microbiological and Biomedical Laboratories,”. 3rd Ed. U.S. Department of Health and Human Services U.S. Government Printing Office; Washington D.C.: 1993. 1993-017-040-00523-17. HHS Publication No. (CDC) 93-8395. [Google Scholar]
  22. Cheprunov A.A., Chuev Y.P., P’yankov V., Efimova I.V. Effects of some physical and chemical factors on inactivation of Ebola virus [in Russian] Vopr. Virusol. 1995;40(2):40–43. [PubMed] [Google Scholar]
  23. Cianciolo G.J., Copeland T.J., Oroszlan S., Snyderman R. Inhibition of lymphocyte proliferation by a synthetic peptide homologous to retroviral envelope protein. Science. 1985;230:453–455. doi: 10.1126/science.2996136. [DOI] [PubMed] [Google Scholar]
  24. Conrad J.L., Isaacson M., Smith E.B., Wulff H., Crees M., Geldenhuys P., Johnston J. Epidemiologic investigation of Marburg virus disease, Southern Africa, 1975. Am. J. Trop. Med. Hyg. 1978;27:1210–1215. doi: 10.4269/ajtmh.1978.27.1210. [DOI] [PubMed] [Google Scholar]
  25. Crichton M. “The Andromeda Strain.”. 1969 Dell, New York. [Google Scholar]
  26. Dalgard D.W., Hardy R.J., Pearson S.L., Pucak G.J., Quander R.V., Zack P.M., Peters C.J., Jahrling P.B. Combined simian hemorrhagic fever and Ebola virus infection in cynomolgus monkeys. Lab. Anim. Sci. 1992;42:152–157. [PubMed] [Google Scholar]
  27. Dietrich M., Schumacher H.H., Peters D., Knobloch J. Human pathology of Ebola virus infection in the Sudan. In: Pattyn S.R., editor. “Ebola Virus Hemorrhagic Fever”. Elsevier/North Holland; Amsterdam: 1978. pp. 37–42. [Google Scholar]
  28. Downs W.G. “The Arthropod-Borne Viruses of Vertebrates. An Account of the Rockefeller Foundation Virus Program, 1951–1970.”. Yale Univ. Press; New Haven, Connecticut: 1973. [Google Scholar]
  29. Elliott L.H., Bauer S.P., Perez-Oronoz G., Lloyd E.S. Improved specificity of testing methods for filovirus antibodies. J. Virol. Methods. 1993;43:85–100. doi: 10.1016/0166-0934(93)90092-6. [DOI] [PubMed] [Google Scholar]
  30. Emond R.T.D., Evans B., Bowen E.T.W., Lloyd G. A case of Ebola virus infection. Br. Med. J. 1977;2:541–544. doi: 10.1136/bmj.2.6086.541. [DOI] [PMC free article] [PubMed] [Google Scholar]
  31. Feldmann H., Klenk H.-D. Marburg and Ebola viruses. Adv. Virus Res. 1996;47:1–52. doi: 10.1016/s0065-3527(08)60733-2. [DOI] [PubMed] [Google Scholar]
  32. Feldmann H., Mühlberger E., Randolf A., Will C., Kiley M.P., Sanchez A., Klenk H.-D. Marburg virus, a filovirus: Messenger RNAs, gene order, and regulatory elements of the replication cycle. Virus Res. 1992;24:1–19. doi: 10.1016/0168-1702(92)90027-7. [DOI] [PubMed] [Google Scholar]
  33. Feldmann H., Klenk H.-D., Sanchez A. Molecular biology and evolution of filoviruses. Arch. Virol. 1993;7(Suppl.):81–100. doi: 10.1007/978-3-7091-9300-6_8. [DOI] [PubMed] [Google Scholar]
  34. Feldmann H., Nichol S.T., Klenk H.-D., Peters C.J., Sanchez A. Characterization of filoviruses based on differences in structure and antigenicity of the virion glycoprotein. Virology. 1994;199:469–473. doi: 10.1006/viro.1994.1147. [DOI] [PubMed] [Google Scholar]
  35. Feldmann H., Bugany H., Mahner F., Klenk H.-D., Drenckhahn D., Scnittler H.J. Filovirus-induced endothelial leakage triggered by infected monocytes/macrophages. J. Virol. 1996;70:2208–2214. doi: 10.1128/jvi.70.4.2208-2214.1996. [DOI] [PMC free article] [PubMed] [Google Scholar]
  36. Feldmann H., Slenczka W., Klenk H.-D. Emerging and reemerging of filoviruses. Arch. Virol. 1996;11(Suppl.):77–100. doi: 10.1007/978-3-7091-7482-1_9. [DOI] [PubMed] [Google Scholar]
  37. Fisher-Hoch S.P., Brammer T.L., Trappier S.G., Hutwagner L.C., Farrar B.B., Ruo S.L., Brown B.G., Hermann L.M., Perez-Oronoz G.I., Goldsmith C.S., Hanes M.A., McCormick J.B. Pathogenic potential of filoviruses: Role of geographic origin of primate host and virus strain. J. Infect. Dis. 1992;166:753–763. doi: 10.1093/infdis/166.4.753. [DOI] [PubMed] [Google Scholar]
  38. Fisher-Hoch S.P., Perez-Oronoz G.I., Jackson E.L., Hermann L.M., Brown B.G. Filovirus clearance in non-human primates. Lancet. 1992;340:451–453. doi: 10.1016/0140-6736(92)91770-9. [DOI] [PubMed] [Google Scholar]
  39. Formenty P., Boesch C., LeGuenno B., Akoua-Koffi C., Diarra-Nama J. Natural history of Ebola virus in the Tai Forest, Côte d’Ivoire; Proceedings of International Colloquium on Ebola Virus Research, Antwerp; 1996. [Google Scholar]
  40. Fraser G.C., Hooper P.T., Lunt R.A., Gould A.R., Gleeson L.J., Hyatt A.D., Russell G.M., Kattenbelt J.A. Encephalitis caused by a lyssavirus in fruit bats in Australia. Emerging Infect. Dis. 1996;2(4):327–331. doi: 10.3201/eid0204.960408. [DOI] [PMC free article] [PubMed] [Google Scholar]
  41. Gear J.S.S., Cassel G.A., Gear A.J., Trappler B., Clansen L., Meyers A.M., Kew M.C., Bothwell T.H., Sher R., Miller G.B., Schneider J., Koornhoff H.J., Gomperts E.D., Isaacson M., Gear J.H.S. Outbreak of Marburg virus disease in Johannesburg. Br. Med. J. 1975;4:489–493. doi: 10.1136/bmj.4.5995.489. [DOI] [PMC free article] [PubMed] [Google Scholar]
  42. Geisbert T.W., Jahrling P.B., Hanes M.A., Zack P.M. Association of Ebola-related Reston virus particles and antigen with tissue lesions of monkeys imported to the United States. J. Comp. Pathol. 1992;106:137–152. doi: 10.1016/0021-9975(92)90043-t. [DOI] [PubMed] [Google Scholar]
  43. Geisbert T.W., Jahrling P.B. Differentiation of filoviruses by electron microscopy. Virus Res. 1995;39:129–150. doi: 10.1016/0168-1702(95)00080-1. [DOI] [PubMed] [Google Scholar]
  44. Georges A.J., Renaut A.A., Bertherat E., Baize S., Leroy E., LeGuenno B., Lepage J., Amblard J., Edzang S., Georges Courbot M.C. Recent Ebola virus outbreaks in Gabon from 1994 to 1996: Epidemiologic and control issues; Proceedings of International Colloquium on Ebola Virus Research, Antwerp; 1996. [Google Scholar]
  45. Georges Courbot M.C., Lu C.Y., Lansoud-Soukate J., Leroy E., Baize S. Isolation and partial molecular characterisation of a strain of Ebola virus during a recent epidemic of viral haemorrhagic fever in Gabon. Lancet. 1997;349:181. doi: 10.1016/s0140-6736(05)60983-x. [DOI] [PubMed] [Google Scholar]
  46. Georges Courbot M.C., Sanchez A., Lu C.Y., Baize S., Leroy E., Lansout-Soukate J., Tevi-Benissan C., Georges A.J., Trappier S.G., Zaki S.R., Swanepoel R., Leman P.A., Rollin P.E., Peters C.J. Isolation and phylogenetic characterization of Ebola viruses causing different outbreaks in Gabon. Emerging Infect. Dis. 1997;3:59–62. doi: 10.3201/eid0301.970107. [DOI] [PMC free article] [PubMed] [Google Scholar]
  47. Gonzalez J.-P., Josse R., Johnson E.D. Antibody prevalence against hemorrhagic fever viruses in randomized representative Central Africa populations. Res. Viral. 1989;140:319–331. doi: 10.1016/s0923-2516(89)80112-8. [DOI] [PubMed] [Google Scholar]
  48. Gonzalez J.-P. Human and animal filovirus surveillance in endemic areas of central Africa. Proceedings of International Colloquium on Ebola Virus Research, Antwerp. 1996 [Google Scholar]
  49. Hayes C.G., Buran J.P., Ksiazek T.G., Del Rosario R.A., Miranda M.E.G., Manaloto C.R., Barrientos A.B., Robles C.G., Dayrit M.M., Peters C.J. Outbreak of fatal illness among captive macaques in the Philippines caused by an Ebola-related filovirus. Am. J. Trop. Med. Hyg. 1992;46:664–671. doi: 10.4269/ajtmh.1992.46.664. [DOI] [PubMed] [Google Scholar]
  50. Heymann D.L., Weisfeld J.S., Webb P.A., Johnson K.M., Cairns T., Berquist H. Ebola hemorrhagic fever: Tandala, Zaire, 1977-78. J. Infect. Dis. 1980;142:373–376. doi: 10.1093/infdis/142.3.372. [DOI] [PubMed] [Google Scholar]
  51. Holland J.J., editor. Genetic diversity of RNA viruses. Vol. 176. 1993. pp. 1–226. (Curr. Top. Microbial. Immunol.). [Google Scholar]
  52. Huggins J., Tseng C., Laughlin C., Bray M. Antiviral drug therapy for filovirus infections. Proceedings of International Colloquium on Ebola Virus Research, Antwerp. 1996 [Google Scholar]
  53. Ivker R. Argument over Ebola in Gabon. Lancet. 1997;349:264. [Google Scholar]
  54. Jaax N., Jahrling P., Geisbert T., Geisbert J., Steele K., McKee K., Nagley D., Johnson E., Jaax G., Peters C. Transmission of Ebola virus (Zaire strain) to uninfected control monkeys in a biocontainment laboratory. Lancet. 1995;346:1669–1671. doi: 10.1016/s0140-6736(95)92841-3. [DOI] [PubMed] [Google Scholar]
  55. Jaax N.K., Davis K.J., Geisbert T.J., Vogel P., Jaax G.P., Topper M., Jahrling P.B. Lethal experimental infection of rhesus monkeys with Ebola-Zaire (Mayinga) virus by the oral and conjunctival route of exposure. Arch. Pathol. Lab. Med. 1996;120:140–155. [PubMed] [Google Scholar]
  56. Jahrling P.B., Geisbert T.W., Dalgard D.W., Johnson E.D., Ksiazek T.G., Hall W.C., Peters C.J. Preliminary report: Isolation of Ebola virus from monkeys imported to USA. Lancet. 1990;335:502–505. doi: 10.1016/0140-6736(90)90737-p. [DOI] [PubMed] [Google Scholar]
  57. Jahrling P.B., Geisbert T.W., Jaax N.K., Hanes M.A., Ksiazek T.G., Peters C.J. Experimental infection of cynomolgus macaques with Ebola-Reston filoviruses from the 1989–1990 U.S. epizootic. Arch. Virol. 1996;ll:115–134. doi: 10.1007/978-3-7091-7482-1_11. Suppl. [DOI] [PubMed] [Google Scholar]
  58. Jahrling P.B., Geisbert J., Swearengen J.R., Jaax G.P., Lewis T., Huggins J.W., Schmidt J.J., LeDuc J.W., Peters C.J. Passive immunization of Ebola virus-infected cynomolgus monkeys with immunoglobulin from hyperimmune horses. Arch. Virol. 1996;11:135–140. doi: 10.1007/978-3-7091-7482-1_12. Suppl. [DOI] [PubMed] [Google Scholar]
  59. Johnson E.D., Gonzales J.-P., Georges A. Haemorhagic fever virus activity in equatorial Africa: Distribution and prevalence of filovirus reactive antibody in the Central African Republic. Trans. R. Soc. Trop. Med. Hyg. 1993;87:530–535. doi: 10.1016/0035-9203(93)90075-2. [DOI] [PubMed] [Google Scholar]
  60. Johnson E.D., Gonzales J.-P., Georges A. Filovirus activity among selected ethnic groups inhabiting the tropical forest of equatorial Africa. Trans. R. Soc. Trop. Med. Hyg. 1993;87:536–538. doi: 10.1016/0035-9203(93)90077-4. [DOI] [PubMed] [Google Scholar]
  61. Johnson E.D., Jaax N., White J., Jahrling P. Lethal experimental infections of rhesus monkeys by aeorsolized Ebola virus. Int. J. Exp. Patbol. 1995;76:227–236. [PMC free article] [PubMed] [Google Scholar]
  62. Johnson E.D., Johnson B.K., Silverstein D., Tukei P., Geisbert T.W., Sanchez A.N., Jahrling P.B. Characterization of a new Marburg virus isolated from a 1987 fatal case in Kenya. Arch. Virol., Suppl. 1996;11:101–114. doi: 10.1007/978-3-7091-7482-1_10. [DOI] [PubMed] [Google Scholar]
  63. Johnson K.M., Webb P.A., Lange J.V., Murphy F.A. Isolation and characterization of a new virus [Ebola virus] causing acute hemorrhagic fever in Zaire. Lancet. 1977;1:569–571. doi: 10.1016/s0140-6736(77)92000-1. [DOI] [PubMed] [Google Scholar]
  64. Johnson K.M., Webb P.A., Justines G., Murphy F.A. “Third Munich Symposium on Microbiology: Natural History of Emerging and Re-emerging Viral Zoonoses, Munich, 1978.”. UNI-Druck; Munich: 1978. Ecology of hemorrhagic fever viruses: Arenavirus biology and the Marburg-Ebola riddle. [Google Scholar]
  65. Johnson K.M., Scribner C.L., McCormick J.B. Ecology of Ebola virus: A first clue? J. Infect. Dis. 1981;143:749–751. doi: 10.1093/infdis/143.5.749. [DOI] [PubMed] [Google Scholar]
  66. Kadota J., Cianciolo G.J., Snyderman R. A synthetic peptide homologous to retroviral transmembrane envelope proteins depress protein kinase C mediated lymphocyte proliferation and directly inactivates protein kinase C: A potential mechanism for immunosuppression. Microbial. Immunol. 1991;35:443–459. doi: 10.1111/j.1348-0421.1991.tb01575.x. [DOI] [PubMed] [Google Scholar]
  67. Khan A.S., Mungala K., Commission de Lutte Controle de Epidemies á Kikwit Epidemiologic features of the recent Ebola virus outbreaks: Epidemiologic and control issues—Kikwit, Zaire 1995. Proceedings of International Colloquium on Ebola Virus Research, Antwerp. 1996 [Google Scholar]
  68. Kikiforov V.V., Turovskii I.I., Kalinin P.P., Akinfeeva L.A., Katkova L.R., Barmin V.S., Raibchikova E.I., Popkova N.I., Shestopalov A.m., Nazarov V.P. A case of a laboratory infection with Marburg fever [in Russian] Zh. Mikrobiol. Epidemiol. Immunobiol. 1994;3:104–106. [PubMed] [Google Scholar]
  69. Kilbourne E.D. Are new diseases really new? Natural History. 1983;92:28–32. [Google Scholar]
  70. Kilbourne E.D. The emergence of emerging diseases: A lesson in holistic epidemiology. Mount Sinai J. Med. 1996;63:159–166. [PubMed] [Google Scholar]
  71. Kiley M.P., Bowen E.T.W., Eddy G.A., Isaacson M., Johnson K.M., McCormick J.B., Murphy F.A., Pattyn S.R., Peters D., Prozesky O.W., Regnery R.L., Simpson D.I.H., Slenczka W., Sureau P., van der Groen G., Webb P.A., Wulff H. Filoviridae: A taxonomic home for Marburg and Ebola viruses? Intervirology. 1982;18:24–32. doi: 10.1159/000149300. [DOI] [PubMed] [Google Scholar]
  72. Kiley M.P., Cox N.J., Elliott L.H., Sanchez A., DeFries R., Buchmeier M.J., Richman D.D., McCormick J.B. Physiochemical properties of Marburg virus: Evidence for three distinct virus strains and their relationship to Ebola virus. J. Gen. Virol. 1988;69:1957–1967. doi: 10.1099/0022-1317-69-8-1957. [DOI] [PubMed] [Google Scholar]
  73. Kissling R.E., Robinson R.Q., Murphy F.A., Whitfield S.G. Agent of disease contracted from green monkeys. Science. 1968;160:888–890. doi: 10.1126/science.160.3830.888. [DOI] [PubMed] [Google Scholar]
  74. Kissling R.E., Murphy F.A., Henderson B.E. Marburg virus. Ann. N. Y. Acad. Sci. 1970;174:932–945. doi: 10.1111/j.1749-6632.1970.tb45614.x. [DOI] [PubMed] [Google Scholar]
  75. Ksiazek T.G. Search for the Ebola reservoir near Kikwit. Proceedings of International Colloquium on Ebola Virus Research, Antwerp. 1996 [Google Scholar]
  76. Ksiazek T.G., Rollin P.E., Jahrling P.B., Johnson E.D., Dalgard D.W., Peters C.J. Enzyme immunosorbent assay for Ebola virus antigens in tissues of infected primates. J. Clin. Microbial. 1992;30:947–950. doi: 10.1128/jcm.30.4.947-950.1992. [DOI] [PMC free article] [PubMed] [Google Scholar]
  77. Lederberg J., Shope R.E., Oaks S. “Emerging Microbial Threats.”. U.S. National Academy of Sciences Press; Washington D.C.: 1992. [PubMed] [Google Scholar]
  78. LeGuenno B. Recent Ebola virus outbreak, Côte d'Ivoire and Liberia, 1994–1996. Proceedings of International Colloquium on Ebola Virus Research, Antwerp. 1996 [Google Scholar]
  79. LeGuenno B., Formenty P., Wyers M., Gounon P., Walker F., Boesch C. Isolation and partial characterisation of a new strain of Ebola virus. Lancet. 1995;345:1271–1274. doi: 10.1016/s0140-6736(95)90925-7. [DOI] [PubMed] [Google Scholar]
  80. Lloyd E.S., Rollin P.E., Zaki S.R. Long term surveillance for Ebola in Africa. Proceedings of International Colloquium on Ebola Virus Research, Antwerp. 1996 [Google Scholar]
  81. Luchko S.V., Dadaeva A.A., Ustinova E.N., Sizikova L.P., Riabchikova E.I., Sandakhchiev L.S. Experimental study of Ebola hemorrhagic fever in baboon models [in Russian] Byull. Eksp. Biol. Med. 1995;120:302–304. [PubMed] [Google Scholar]
  82. Markin V.A., Mikhailov V.V., Krasnianskii V.P., Borisevich I.V., Firsova I.V. Developing principles for emergency prevention and treatment of Ebola fever [in Russian] Vopr. Virusol. 1997;42:31–34. [PubMed] [Google Scholar]
  83. Martini G.A., Siegert R. “Marburg Virus Disease.”. Springer-Verlag; Berlin: 1971. [Google Scholar]
  84. Meunier D.M., DuPont A., Madelon M.C., Gonzalez J.-P., Ivanoff B. Serological study of haemorrhagic fevers in the province of Haut-Ogooue. Gabon. Ann. Inst. Pasteur/Virol. 1987;138:229–235. [Google Scholar]
  85. Meunier D.M., Johnson E.D., Gonzalez J.-P., Georges Courbot M.C., Madelon M.C., Georges A.J. Current serological data on viral hemorrhagic fevers in the Central African Republic. Bull. Soc. Exp. Pathol. 1987;80:51–61. [PubMed] [Google Scholar]
  86. Mikhailov W., Borisevich I.V., Chernikova N.K., Rotryvaeva N.V., Krasnianskii V.P. Evaluation of the possibility of Ebola fever specific prophylaxis in baboons [in Russian] Vopr. Virusol. 1994;39:82–84. [PubMed] [Google Scholar]
  87. Mims C.A. The origin of major human infections and the crucial role of human-to-human spread. Epidemiol. Infect. 1991;106:423–433. doi: 10.1017/s0950268800067479. [DOI] [PMC free article] [PubMed] [Google Scholar]
  88. Muhlberger E., Sanchez A., Randolf A., Will C., Kiley M.P., Klenk H.-D., Feldmann H. The nucleotide sequence of the L gene of Marburg virus, a filovirus: Homologies with paramyxoviruses and rhabdoviruses. Virology. 1992;187:534–547. doi: 10.1016/0042-6822(92)90456-y. [DOI] [PubMed] [Google Scholar]
  89. Monath T.P. Speculations on the natural history of Ebola virus and experimental approaches. Proceedings of International Colloquium on Ebola Virus Research, Antwerp. 1996 [Google Scholar]
  90. Murphy F.A. Pathology of Ebola virus infection. In: Pattyn S.R., editor. “International Colloquium on Ebola Virus Infection and Other Hemorrhagic Fevers”. Elsevier/North Holland; Amsterdam: 1978. pp. 43–60. [Google Scholar]
  91. Murphy F.A. New, emerging and reemerging infectious diseases. Adv. Virus Res. 1993;43:1–38. doi: 10.1016/s0065-3527(08)60046-9. [DOI] [PubMed] [Google Scholar]
  92. Murphy F.A., Fauquet C.M., Bishop D.H.L., Ghabrial S.A., Jarvis A.W., Martelli G.P., Mayo M.A., Summers M.D. The Sixth Report of the International Committee on Taxonomy of Viruses. Springer-Verlag; Vienna: 1995. “Virus Taxonomy: The Classification and Nomenclature of Viruses,”; pp. 1–600. [Google Scholar]
  93. Murphy F.A., Nathanson N. The emergence of new virus diseases: An overview. In “New and Emerging Viral Diseases” (F. A. Murphy and N. Nathanson, eds.), Semin. Virol. 1994;5(2):1–102. [Google Scholar]
  94. Murphy F.A., Nathanson N. An atlas of viral disease pathogenesis. In: Nathanson N., Murphy F.A., Ahmed R., Holmes K., Griffin D., Gonzales F., Robinson H., editors. “Viral Pathogenesis”. Lippincott-Raven; Philadelphia: 1996. pp. 433–463. [Google Scholar]
  95. Murphy F.A., Simpson D.I.H., Whitfield S.G., Zlotnik I., Carter G.B. Marburg virus infection in monkeys. Lab. Invest. 1971;24:279–291. [PubMed] [Google Scholar]
  96. Murphy F.A., van der Groen G., Whitfield S.G., Lange J.V. Ebola and Marburg virus morphology and taxonomy. In: Pattyn S.R., editor. “International Colloquium on Ebola Virus Infection and Other Hemorrhagic Fevers”. Elsevier/North Holland; Amsterdam: 1978. pp. 61–82. [Google Scholar]
  97. Murray P., Selleck P., Hooper P., Hyatt A., Gould A., Gleeson L. A morbillivirus that caused fatal disease in horses and humans. Science. 1995;268:94–97. doi: 10.1126/science.7701348. [DOI] [PubMed] [Google Scholar]
  98. Muyembe-Tamfun J.J., Kipasa M. Ebola haemorrhagic fever in Kikwit, Zaire. International Scientific and Technical Committee and World Health Organization Collaborating Centre for Haemorrhagic Fevers. Lancet. 1995;345:1448. doi: 10.1016/s0140-6736(95)92640-2. [DOI] [PubMed] [Google Scholar]
  99. Muyembe-Tamfun J.J., World Health Organization International Scientific and Technical Committee Ebola Kikwit outbreak: Discovery and control measures. Proceedings of International Colloquium on Ebola Virus Research, Antwerp. 1996 [Google Scholar]
  100. Nathanson N., Murphy F.A. Evolution of viral diseases. In: Nathanson N., F. A. Murphy, Ahmed R., Holmes K., Griffin D., Gonzales F., Robinson H., editors. “Viral Pathogenesis”. Lippincott-Raven; Philadelphia: 1996. pp. 353–370. [Google Scholar]
  101. Nichol S.T., Ksiazek T.G. Isolation and phylogenetic characterization of Ebola viruses causing different outbreaks in Gabon. Emerging Infect. Dis. 1997;3:59–62. doi: 10.3201/eid0301.970107. [DOI] [PMC free article] [PubMed] [Google Scholar]
  102. Olson P.E., Hames C.S., Benenson A.S., Genovese E.N. The Thucydides syndrome: Ebola déjà vu? (or Ebola reemergent?) Emerging Infect. Dis. 1996;2:155–156. doi: 10.3201/eid0202.960220. [DOI] [PMC free article] [PubMed] [Google Scholar]
  103. P'yankov O.V., A. N. Sergeev, P'yankova O.G., Chepurnov A.A. Experimental Ebola fever in Macaca rhesus [in Russian] Vopr. Virusol. 1995;3:113–115. [PubMed] [Google Scholar]
  104. Panum P.L. Observations Made during the Epidemic of Measles on the Faroe Islands in the year 1846. American Public Health Association; New York: 1940. [Google Scholar]
  105. Pattyn S.R. “Ebola Virus Hemorrhagic Fever.”. Elsevier/North-Holland; Amsterdam: 1978. [Google Scholar]
  106. Pereboeva L.A., Tkachev V.K., Kolesnikova L.V., Krendeleva L.I., Riabchikova E.I., Smolina M.P. The ultrastructural changes in guinea pig organs during the serial passage of the Ebola virus [in Russian] Vopr. Virusol. 1993;38:179–l82. [PubMed] [Google Scholar]
  107. Peters C.J. Emerging infections—Ebola and other filoviruses. West. J. Med. 1996;164:36–38. [PMC free article] [PubMed] [Google Scholar]
  108. Peters C.J. Pathogenesis of viral hemorrhagic fevers. In: Nathanson N., Ahmed R., Gonzalez-Scarano F., Griffin D., Holmes K.V., Murphy F.A., Robinson H.L., editors. “Viral Pathogenesis”. Lippincott-Raven; Philadelphia: 1996. pp. 779–800. [Google Scholar]
  109. Peters C.J., Johnson E.D., Jahrling P.B., Ksiazek T.G., Rollin P.E., White J., Hall W., Trotter R., Jaax N. Filoviruses. In: Morse S., editor. “Emerging Viruses”. Oxford Univ. Press; New York: 1991. pp. 159–175. [Google Scholar]
  110. Peters C.J., Johnson E.D., McKee K.T. Filoviruses and management of viral hemorhagic fevers. In: Belshe R.B., editor. “Textbook of Human Virology”. Mosby Year Book; St. Louis: 1991. pp. 699–712. [Google Scholar]
  111. Peters C.J., Sanchez A., Feldmann H., Rollin P.E., Nichol S., Ksiazek T.G. Filoviruses as emerging pathogens. Semin. Virol. 1994;5:147–154. [Google Scholar]
  112. Peters C.J., Sanchez A., Rollin P.E., Ksiazek T.G., Murphy F.A. Filoviridae: Marburg and Ebola viruses. In: Fields B.N., Knipe D.M., editors. “Virology”. 3rd Ed. Raven Press; New York: 1996. pp. 11617–21176. [Google Scholar]
  113. Piot P., Sureau P., Breman J., Heymann D., Kintoki V., Masamba M., Mbuyi, Miatudila M., Ruppol M., Van Nieuwenhove S., White M.K., van der Groen G., Webb P.A., Wulff H., Johnson K.M. Clinical aspects of Ebola virus infection in Yambuku area, Zaire, 1976. In: Pattyn S.R., editor. “Ebola Virus Hemorrhagic Fever”. Elsevier/North-Holland; Amsterdam: 1978. [Google Scholar]
  114. Pokhodyaeu V.A., Gonchar N.I., Pshenichnov V.A. Experimental study of Marburg virus contact transmission [in Russian] Vopr. Virusol. 1991;36:506–508. [PubMed] [Google Scholar]
  115. Regnery K.L., Johnson K.M., Kiley M.P. Marburg and Ebola viruses: Possible members of a new group of negative strand viruses. In: Bishop D.H.L., Compans R.W., editors. “The Replication of Negative Strand Viruses”. Elsevier/North-Holland; Amsterdam: 1981. pp. 971–977. [Google Scholar]
  116. Ryabchikova E.I., Baranova S.G., Tkachev V.K., Grazhdantseva A.A. The morphological changes in Ebola infection in guinea pigs [in Russian] Vopr. Virusol. 1993;38:176–179. [PubMed] [Google Scholar]
  117. Ryabchikova E., Kolesnikova L., Smolina M., Tkachev V., Pereboeva L., Baranova S., Grazhdantseva A., Rassadkin Y. Ebola virus infection in guinea pigs: Presumable role of granulomatous inflammation in pathogenesis. Arch. Virol. 1996;141:909–921. doi: 10.1007/BF01718165. [DOI] [PubMed] [Google Scholar]
  118. Sanchez A., Kiley M.P., Klenk H.-D., Feldmann H. Sequence analysis of the Marburg virus nucleoprotein gene: Comparison to Ebola virus and other non-segmented negative-strand RNA viruses. J. Gen. Virol. 1992;73:347–357. doi: 10.1099/0022-1317-73-2-347. [DOI] [PubMed] [Google Scholar]
  119. Sanchez A., Kiley M.P., Holloway B.P., Auperin D.D. Sequence analysis of the Ebola virus genome: Organization, genetic elements, and comparison with the genome of Marburg virus. Virus Res. 1993;29:215–240. doi: 10.1016/0168-1702(93)90063-s. [DOI] [PubMed] [Google Scholar]
  120. Sanchez A., Ksiazek T.G., Rollin P.E., Peters C.J., Nichol S.T., Khan A.S., Mahy B.W.J. Reemergence of Ebola virus in Africa. Emerging Infect. Dis. 1995;1:96–97. doi: 10.3201/eid0103.950307. [DOI] [PMC free article] [PubMed] [Google Scholar]
  121. Sanchez A., Trappier S.G., Mahy B.W.J., Peters C.J., Nichol S.T. The virion glycoproteins of Ebola viruses are encoded in two reading frames and are expressed through transcriptional editing. Proc. Natl. Acad. Sci. U.S.A. 1996;93:3602–3607. doi: 10.1073/pnas.93.8.3602. [DOI] [PMC free article] [PubMed] [Google Scholar]
  122. Schnittler H.J., Mahner F., Drenckhahn D., Klenk H.-D., Feldmann H. Replication of Marburg virus in human endothelial cells. A possible mechanism for the development of viral hemorrhagic disease. J. Clin. Invest. 1993;91:1301–1309. doi: 10.1172/JCI116329. [DOI] [PMC free article] [PubMed] [Google Scholar]
  123. Siegert R., Shu H.L., Slenczka W., Peters D., Muller G. Zur Atiologie einer unbekannten, von Affen ansgegangen menschlichen Infektionskrankheit. Dtsch. Med. Wochenschr. 1967;92:2341–2343. doi: 10.1055/s-0028-1106144. [DOI] [PubMed] [Google Scholar]
  124. Simpson D.I.H. “Marburg Virus: A Review of Laboratory Studies.”. Balnaer and Beveridge; Munksgaard, Copenhagen: 1970. [Google Scholar]
  125. Simpson D.I.H. The filovirus enigma. Lancet. 1995;345:1252–1253. doi: 10.1016/s0140-6736(95)90918-4. [DOI] [PubMed] [Google Scholar]
  126. Smith C.E.G., Simpson D.I.H., Bowen E.T.W. Fatal human disease from vervet monkeys. Lancet. 1967;2:1119–1121. doi: 10.1016/s0140-6736(67)90621-6. [DOI] [PubMed] [Google Scholar]
  127. Smith D.H., Johnson B.K., Isaacson M., Swanepoel R., Johnson K.M., Kiley M., Bagshawe A., Tarap Siongok, Koinange Keruga W. Marburg virus disease in Kenya. Lancet. 1982;1:816–820. doi: 10.1016/s0140-6736(82)91871-2. [DOI] [PubMed] [Google Scholar]
  128. Stansfield S.K., Scribner C.L., Kaminski R.M., Cairns T., McCormick J.B., Johnson K.M. Antibody to Ebola virus in guinea pigs: Tandala, Zaire. J. Infect. Dis. 1982;146:483–486. doi: 10.1093/infdis/146.4.483. [DOI] [PubMed] [Google Scholar]
  129. Swanepoel R., Leman P.A., Burt F.J., Braack L. Studies on the ecology of filoviruses in southern Africa. Proceedings of International Colloquium on Ebola Virus Research, Antwerp. 1996 [Google Scholar]
  130. Swanepoel R., Leman P.A., Burt F.J., Zachariades N.A., Braack L.E., Ksiazek T.G., Rollin P.E., Zaki S.R., Peters C.J. Experimental inoculation of plants and animals with Ebola virus. Emerging Infect. Dis. 1996;2:321–325. doi: 10.3201/eid0204.960407. [DOI] [PMC free article] [PubMed] [Google Scholar]
  131. Teepe R.G., Johnson B.K., Ocheng D., Gichogo A., Lnagatt A., Ngindu A., Kiley M.P., Johnson K.M., McCormick J.B. A probable case of Ebola virus hemorrhagic fever in Kenya. East Afr. Med. J. 1983;60:718–722. [PubMed] [Google Scholar]
  132. Tukei P.M. Threat of Marburg and Ebola viral haemorrhagic fevers in Africa. East AMY. Med. J. 1996;73:27–31. [PubMed] [Google Scholar]
  133. Turrell M.J., Bressler D.S., Rossi C.A. Lack of virus replication in arthropods after intrathoracic inoculation of Ebola Reston virus. Am. J. Trop. Med. Hyg. 1996;55:89–90. doi: 10.4269/ajtmh.1996.55.89. [DOI] [PubMed] [Google Scholar]
  134. van der Groen G., Webb P.A., Johnson K.M., Lange J., Lindsay H., Elliott L. Growth of Lassa and Ebola viruses in different cell lines. In: S. R. Pattyn., editor. “Ebola Virus Hemorrhagic Fever”. Elsevier/North-Holland; Amsterdam: 1978. pp. 255–260. [Google Scholar]
  135. van der Walls F.J., Pomerov K.L., Goudsmit J., Asher D.M., Gajdusek D.C. Hemorrhagic fever virus infections in an isolated rainforest area of central Liberia. Limitations of the indirect immunofluorescence slide test for antibody screening in Africa. Trop. Geogr. Med. 1986;38:209–214. [PubMed] [Google Scholar]
  136. Volchkov V.E., Blinov V.M., Netesov S.V. The envelope glycoprotein of Ebola virus contains an immunosuppressive-like domain similar to oncogenic retroviruses. FEBS Lett. 1995;305:181–184. doi: 10.1016/0014-5793(92)80662-z. [DOI] [PubMed] [Google Scholar]
  137. World Health Organization Ebola haemorrhagic fever in Sudan, 1976. Report of a World Health Organization International Study Team. BUZZ. WHO. 1978;56:247–270. [PMC free article] [PubMed] [Google Scholar]
  138. World Health Organization Ebola haemorrhagic fever in Zaire, 1976. Report of an international commission. Bull. WHO. 1978;56:271–293. [PMC free article] [PubMed] [Google Scholar]
  139. World Health Organization Viral hemorrhagic fever surveillance. BUZZ. WHO. 1979;57:342–343. [Google Scholar]
  140. World Health Organization Viral hemorrhagic fever surveillance. Bull. WHO. 1982;57:359. [Google Scholar]
  141. World Health Organization Ebola haemorrhagic fever. Weekly Epidemiol. Rec. 1995;70:147–148. [PubMed] [Google Scholar]
  142. World Health Organization Ebola haemorrhagic fever. Weekly Epidemiol. Rec. 1995;70:149–151. [PubMed] [Google Scholar]
  143. World Health Organization Ebola haemorrhagic fever. Weekly Epidemiol. Rec. 1995;70:158. [Google Scholar]
  144. World Health Organization Ebola haemorrhagic fever. Weekly Epidemiol. Rec. 1995;70:241–242. [PubMed] [Google Scholar]
  145. World Health Organization Ebola haemorrhagic fever. Weekly Epidemiol. Rec. 1996;71:320. [PubMed] [Google Scholar]
  146. World Health Organization Ebola haemorrhagic fever. Weekly Epidemiol. Rec. 1997;72:7–8. [Google Scholar]
  147. Young P.L., Halpin K., Selleck P.W., Field H., Gravel J.L., Kelly M.A., Mackenzie J.S. Serologic evidence for the presence in pteropus bats of a paramyxovirus related to equine morbillivirus. Emerging Infect. Dis. 1996;2:239–240. doi: 10.3201/eid0203.960315. [DOI] [PMC free article] [PubMed] [Google Scholar]
  148. Zaki S.R., Greer P.W., Goldsmith C.S., Coffield L.M. Ebola hemorrhagic fever: Pathologic, immunopathologic and ultrastructural study. Proceedings of International Colloquium on Ebola Virus Research, Antwerp. 1996 [Google Scholar]
  149. Zaki S.R., Greer P.W., Goldsmith C.S., Coffield L.M., Rollin P., Calain P., Khan A.S., Ksiazek T.G., Peters C.J. Ebola hemorrhagic fever: Pathologic, immunopathologic and ultrastructural study. Lab. Invest. 1996;74:133–145. [Google Scholar]

Articles from Biomedical Research Reports are provided here courtesy of Elsevier

RESOURCES